Benzinga | Oct 14, 2020 06:42AM EDT

UBS Initiates Coverage On DocuSign with Buy Rating, Announces Price Target of $290

UBS analyst Karl Keirstead initiates coverage on DocuSign (NASDAQ:DOCU) with a Buy rating and announces Price Target of $290.